To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is
Reconstitute with the diluent specified in your protocol, swirl gently rather than shaking to avoid shearing the peptide, and store the working solution refrigerated
Zero randomized, placebo-controlled human trials for BPC-157 and knee injuries exist as of March 2026
For widespread eczema covering large body surface areas, systemic delivery (subcutaneous injection) ensures all affected areas receive benefit without the impracticality of applying topical preparations everywhere
Disclaimer: For Research Purposes Only This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research
Neither medicine is currently licensed in the UK, but early clinical trial data are promising
